Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2020-04-27 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2020
Transaction in Own Shares Classification · 98% confidence The document explicitly details transactions under a 'stock buyback program' conducted by Novozymes, providing accumulated figures, daily transaction tables, and detailed trade logs with volume, price, and venue. This content directly relates to the company managing its own shares through repurchase activities. According to the definitions, 'Transaction in Own Shares (Code: POS)' covers 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. Although it is a detailed report, the primary subject matter fits POS better than any other category. It is not a general regulatory filing (RNS) because it is highly specific, nor is it a major shareholding notification (MRQ) which concerns external shareholders crossing thresholds. It is a report detailing the company's own share transactions.
2020-04-27 English
Transaction in Own Shares 2020
Transaction in Own Shares Classification · 100% confidence The document text is extremely short (401 characters) and explicitly states, 'Please read the full announcement in the attached PDF' and provides a link to a document titled 'Transactions under Novozymes’s stock buyback program'. This indicates the document itself is merely an announcement about a transaction involving the company's own shares (a buyback program) and directs the reader elsewhere for the full details. According to Rule #2 (The 'Menu vs Meal' Rule), a short announcement pointing to a full report should be classified as a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Since the subject matter is clearly about the company buying back its own shares, the most specific category is Transaction in Own Shares (POS). However, because this specific text is only the announcement wrapper pointing to the actual filing/details, RPA is a strong candidate. Given the specific nature of the underlying event (stock buyback), POS is the intended subject, but the format strongly suggests RPA. Since the content is about a 'Transaction in Own Shares' (POS), and this is a direct announcement of that activity, I will prioritize the subject matter (POS) over the wrapper format (RPA), as POS filings often contain a brief summary before linking to the full regulatory filing. If the document were longer and contained the details, it would be POS. As it is a very short announcement about a POS event, I will classify it as POS, recognizing the ambiguity introduced by the short length.
2020-04-27 English
Transaction in Own Shares 2020
Transaction in Own Shares Classification · 100% confidence The document text is extremely short (401 characters) and explicitly states, "Please read the full announcement in the attached PDF" and provides a link to a document titled "Transactions under Novozymes’s stock buyback program". This indicates the document itself is merely an announcement about a transaction involving the company's own shares (a buyback program), rather than the detailed regulatory filing detailing the transaction itself. According to Rule 2 (The "MENU VS MEAL" Rule), a short announcement pointing to a full document should be classified as a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Since the subject matter is clearly about the company buying back its own shares, the most specific category is Transaction in Own Shares (POS). However, because this text is only an announcement pointing to the actual filing/report, it fits the RPA definition best, as it announces the publication of information. Given the specific nature of the content (stock buyback), POS is the underlying topic, but the format strongly suggests RPA or RNS. Since RPA is defined as 'Announcement regarding the timing, release, or publication of company reports', and this is an announcement of a transaction report, RPA is the most appropriate classification based on the document structure and length.
2020-04-20 English
Transaction in Own Shares 2020
Transaction in Own Shares Classification · 98% confidence The document explicitly discusses 'Transactions under Novozymes' stock buyback program' and details the number of shares purchased, transaction values, and specific dates (April 14-17, 2020). It references a previous 'Company announcement No. 1, 2020' and is itself labeled as 'Company announcement No. 25' dated April 20, 2020. The core content is a report on the execution of a share repurchase plan. This directly matches the definition for 'Transaction in Own Shares' (POS), which covers company buying back or selling its own shares (share repurchase/issuance). It is not a general regulatory filing (RNS) because it fits a specific category, nor is it a general announcement of a report (RPA) as it contains the detailed data itself.
2020-04-20 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from Novozymes regarding their share buyback program. It details the number of shares purchased, the transaction values, and provides a comprehensive appendix of individual trade data. This falls under the category of 'Transaction in Own Shares' (POS), as it reports the company buying back its own shares in accordance with regulatory requirements.
2020-04-20 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 95% confidence The document is a short announcement regarding Novozymes' share buyback program. It explicitly states 'Læs venligst hele meddelelsen i vedhæftede fil' (Please read the full announcement in the attached file) and provides a link to the actual report. Following the 'Menu vs Meal' rule, this is an announcement of a report/transaction rather than the full report itself. Since it specifically concerns the company buying back its own shares, it falls under the 'Transaction in Own Shares' category.
2020-04-20 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.